{"DataElement":{"publicId":"2180953","version":"1","preferredName":"Glucksberg Liver Graft Versus Host Disease Stage","preferredDefinition":"Numeric descriptor of stage relating to the Glucksberg criteria for the assessment of acute GVHD in the liver. [Manually-curated]","longName":"GLUCK_LIV_AGVHD_STG","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2180951","version":"1","preferredName":"Glucksberg Liver Graft Versus Host Disease","preferredDefinition":"Relating to the Glucksberg criteria for the assessment of acute GVHD in the liver.","longName":"GLUCK_LIV_GVHD","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2660120","version":"1","preferredName":"Glucksberg Scale Liver","preferredDefinition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).:A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.","longName":"C42297:C12392","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucksberg Scale","conceptCode":"C42297","definition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33DA6504-02D7-121A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-26","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-26","modifiedBy":"ONEDATA","dateModified":"2007-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2180944","version":"1","preferredName":"Graft Versus Host Disease","preferredDefinition":"Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","longName":"Graft Versus Host Disease","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C0018133","definition":"Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2F0AC9A-50D9-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2F0AC9A-50FE-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-02-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2766458","version":"1","preferredName":"Glucksberg Scale Liver Stage","preferredDefinition":"An enumerated set of values using Glucksberg Diagnostic Criteria to evaluate and stage acute GVHD._The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death)._A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._","longName":"GLUCK_LIVER_STG","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Stage 1: Bilirubin 2-3 mg/dL","ValueMeaning":{"publicId":"2766459","version":"1","preferredName":"Stage 1: Bilirubin 2-3 mg/dL","longName":"2766459","preferredDefinition":"Stage 1: Bilirubin 2-3 mg/dL in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5210AA10-46E8-6C5E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5210AA10-4701-6C5E-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"REEVESD","dateModified":"2008-07-15","deletedIndicator":"No"},{"value":"2","valueDescription":"Stage 2: Bilirubin 3-6 mg/dL","ValueMeaning":{"publicId":"2766460","version":"1","preferredName":"Stage 2: Bilirubin 3-6 mg/dL","longName":"2766460","preferredDefinition":"Stage 2: Bilirubin 3-6 mg/dL in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5210AA10-470D-6C5E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5210AA10-4726-6C5E-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"REEVESD","dateModified":"2008-07-15","deletedIndicator":"No"},{"value":"3","valueDescription":"Stage 3: Bilirubin 6-15 mg/dL","ValueMeaning":{"publicId":"2766461","version":"1","preferredName":"Stage 3: Bilirubin 6-15 mg/dL","longName":"2766461","preferredDefinition":"Stage 3: Bilirubin 6-15 mg/dL in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5210AA10-4732-6C5E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5210AA10-474B-6C5E-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"REEVESD","dateModified":"2008-07-15","deletedIndicator":"No"},{"value":"4","valueDescription":"Stage 4: Bilirubin >15 mg/dL","ValueMeaning":{"publicId":"2766462","version":"1","preferredName":"Stage 4: Bilirubin >15 mg/dL","longName":"2766462","preferredDefinition":"Stage 4: Bilirubin >15 mg/dL in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5210AA10-4757-6C5E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5210AA10-4770-6C5E-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"REEVESD","dateModified":"2008-07-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2766457","version":"1","preferredName":"Glucksberg Scale Liver Stage","preferredDefinition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).:A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C42297:C12392:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucksberg Scale","conceptCode":"C42297","definition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5210AA10-46B6-6C5E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"ONEDATA","dateModified":"2008-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5210AA10-46C7-6C5E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-15","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"CCR"}],"ReferenceDocuments":[{"name":"Liver Stage","type":"Preferred Question Text","description":"Liver Stage","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D2F0AC9A-5103-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-02-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}